Concepedia

Lanqi Jia

LJ

4

Publications

158

Citations

4

H-Index

2009

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Lanqi Jia is an author at GlaxoSmithKline (United States) specializing in drug development, drug discovery, and medicine.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyDrug DevelopmentMedicinal ChemistryBiochemistryHypertensionDrug AnalysisNatural Sciences

Publications per year

2009–2024

4

Publications

4

Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors

Christopher Jackson, Seth Noorbakhsh, Ranjini K. Sundaram et al. · Cancer Research · 2019 · 92 citations · Full text

Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility

Lanqi Jia, R. David Simpson, Jing Yuan et al. · ACS Medicinal Chemistry Letters · 2011 · 38 citations · Full text

Methyl Group, Hypertension, Medicinal Chemistry +14

Optimization of orally bioavailable alkyl amine renin inhibitors

Zhenrong Xu, Salvacion Cacatian, Jing Yuan et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 18 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Medicine +6

Deubiquitinating enzyme USP28 inhibitor AZ1 alone and in combination with cisplatin for the treatment of non-small cell lung cancer

Yiqiong Song, Longhao Wang, Yuanyuan Zheng et al. · APOPTOSIS · 2024 · 10 citations · Full text

Rows per page

1–4 of 4